Prelude Capital Management’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Prelude Capital Management’s Portfolio AUGX Stock Details AUGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-91,439	Closed	-$215K	–	1647
2024 Q3	$215K	Buy	+91,439	New	+$185K	0.01%	1029

Prelude Capital Management's AUGX Position: Q4 2024 in Review

Prelude Capital Management sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 91,439 shares — an estimated $215K sold.

Prelude Capital Management first reported a position in AUGX in Q3 2024 and held it in 1 quarter. The position peaked at $215K in Q3 2024. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

Prelude Capital Management reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Prelude Capital Management sold 91,439 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $215K.
Prelude Capital Management first reported a position in Augmedix, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
Prelude Capital Management's Augmedix, Inc. Common Stock position peaked at $215K in Q3 2024.
0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on Prelude Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.